Related Experiment Video
Updated: Oct 19, 2025
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Atopic dermatitis is not associated with SARS-CoV-2 outcomes
Uros Rakita1, Trisha Kaundinya2, Armaan Guraya3
1Chicago Medical School, Rosalind Franklin University, North Chicago, IL, 60064, USA.
Atopic dermatitis (AD) does not appear to increase the risk of severe COVID-19 outcomes. This study found no significant difference in hospitalization, symptom severity, or death for COVID-19 patients with AD.
Area of Science:
- Immunology
- Infectious Diseases
- Dermatology
Background:
- Atopic dermatitis (AD) involves immune dysregulation, raising concerns about potential COVID-19 severity.
- Understanding the impact of AD on COVID-19 outcomes is crucial for patient management.
Purpose of the Study:
- To investigate the association between atopic dermatitis and COVID-19 outcomes.
- To evaluate if AD independently influences COVID-19 symptom severity, hospitalization, and mortality.
Main Methods:
- Retrospective cohort study design.
- Inclusion of adult SARS-CoV-2 positive patients with and without diagnosed atopic dermatitis.
- Multivariable logistic regression analysis to assess the impact of AD on various COVID-19 related outcomes.
Main Results:
- Patients with atopic dermatitis showed similar odds of hospitalization, acute care level, and severe-critical COVID-19 compared to those without AD.
- No significant differences were observed in the need for oxygen therapy, extended hospital stays, lingering symptoms, or COVID-19 related mortality.
- Adjusted odds ratios indicated no independent risk for adverse COVID-19 outcomes in individuals with atopic dermatitis.
Conclusions:
- Atopic dermatitis is not identified as an independent risk factor for increased COVID-19 severity or complications.
- Findings suggest that immune dysregulation in AD does not predispose individuals to worse COVID-19 prognosis.
- Further research may explore specific immune pathways in AD and their interaction with SARS-CoV-2 infection.
More Related Videos
06:47Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:24Asthma-III: Symptoms and Complications
Classification of Asthma
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:23Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...